The use of trimethoprim-sulphamethoxazole in urinary tract infections in domiciliary practice.
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001437:Bacteriuria / Q000188:drug therapy; D002675:Child, Preschool; D002908:Chronic Disease; D003875:Drug Eruptions / Q000209:etiology; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D011743:Pyrimidines / Q000627:therapeutic use*; D013420:Sulfamethoxazole / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014295:Trimethoprim / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy*; D014839:Vomiting / Q000139:chemically induced
D000890:Anti-Infective Agents; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole